Nurse Practitioner · Montgomery, AL
NPI
1396410866
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2032 Chestnut Street
Montgomery, AL, 36106
Phone (334) 269-0212
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
136 services
Medicare patients, 2024
81
Average age 75
Drug cost, 2024
$1.6M
983 prescriptions
Company payments, 2025
$922
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katelyn P Pike was code G0420 (face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour), 60 times for 37 patients. In total Katelyn P Pike billed 136 services in 11 codes, and Medicare paid $10K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| G0420 Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | Office | 60 | 37 | $64.41 | $3,865 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 20 | 18 | $9.25 | $185 |
| 99214 Office E&M - Established | Office | 19 | 17 | $59.24 | $1,126 |
By year: 2022 $2,264 for 26 services; 2023 $5,270 for 58 services; 2024 $10K for 136 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katelyn P Pike prescribed most often to Medicare patients was Nifedipine Er (Nifedipine), with 70 prescriptions and refills. In total Katelyn P Pike wrote 983 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nifedipine Er Nifedipine | 70 | 164 | 29 | $1,941 |
| Allopurinol Generic | 69 | 121 | 25 | $366 |
| Irbesartan Generic | 56 | 135 | 25 | $1,008 |
| Kerendia Finerenone | 52 | 76 | 11 | $49K |
| Ozempic Semaglutide | 51 | 63 | 18 | $55K |
| Calcitriol Generic | 47 | 86 | 12 | $1,019 |
| Farxiga Dapagliflozin Propanediol | 46 | 104 | 22 | $56K |
| Chlorthalidone Generic | 40 | 94 | 11 | $614 |
| Famotidine Generic | 38 | 74 | 13 | $733 |
| Candesartan Cilexetil Generic | 30 | 68 | Under 11 | $3,357 |
| Januvia Sitagliptin Phosphate | 27 | 37 | Under 11 | $20K |
| Hydralazine Hcl Generic | 24 | 62 | 13 | $656 |
| Krystexxa Pegloticase | 21 | 28 | Under 11 | $1.3M |
| Carvedilol Generic | 19 | 47 | 13 | $304 |
| Losartan Potassium Generic | 18 | 54 | Under 11 | $223 |
Brand drugs: 256 claims; generic drugs: 727 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katelyn P Pike $922 ($922 in general payments such as food, travel and fees) from 13 companies. The largest payer was Calliditas Therapeutics US Inc. with $197.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $197 |
| Novo Nordisk Inc NVO | 6 | $136 |
| Amgen Inc. AMGN | 6 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $85.55 |
| Ardelyx, Inc. ARDX | 2 | $50.42 |
| OPKO Pharmaceuticals, LLC | 2 | $44.19 |
| Fresenius USA Marketing, Inc. | 2 | $36.66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31.91 |
| Akebia Therapeutics Inc AKBA | 1 | $28.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.